Recently, a new NB classification was proposed by Ackermann et al. [6] who found that alterations in telomere maintenance mechanisms as well as in RAS or p53 pathways better discriminate between high-risk or low-risk NBs than the previous classification. The gene discussed is TP53; the disease is neuroblastoma.